At-Home Collection and Testing for STIs

Editors in Conversation

#Interviews #Jeff #Magazine #Microbiology #Society #Virology #News #Biology #Science #Natural Sciences #Microbe #American Society For Microbiology #ASME #FOX

30:55

A secret field that summons lightning. A massive spiral that disappears into a salt lake. A celestial observatory carved into a volcano. Meet the wild—and sometimes explosive—world of land art, where artists craft masterpieces with dynamite and bulldozers. In our Season 2 premiere, guest Dylan Thuras, cofounder of Atlas Obscura, takes us off road and into the minds of the artists who literally reshaped parts of the Southwest. These works aren’t meant to be easy to reach—or to explain—but they just might change how you see the world. Land art you’ll visit in this episode: - Double Negative and City by Michael Heizer (Garden Valley, Nevada) - Spiral Jetty by Robert Smithson (Great Salt Lake, Utah) - Sun Tunnels by Nancy Holt (Great Basin Desert, Utah) - Lightning Field by Walter De Maria (Catron County, New Mexico) - Roden Crater by James Turrell (Painted Desert, Arizona) Via Podcast is a production of AAA Mountain West Group.…

about a year ago 34:37

MP3•Episode home

So you want validated, at-home, self-collected swabs for STI testing… Here's what you need to know!

Sexually transmitted infection rates continue to climb across the US and while testing for these diseases is widely available, for the most part it requires the patient to go to a local clinic to collect and submit their sample for testing. But, is that really necessary, especially from a test accuracy perspective? Today’s guests answer that exact question. And I’m sure that many, if not all of us would agree that the ability for patients to collect samples outside of a clinical setting has numerous benefits, including what the authors refer to as pseudo-anonymity, increased comfort and ultimately increased access to testing, which would be of particular value for patients that may avoid clinical settings due to various different socioeconomic barriers.

Watch this episode: https://youtu.be/40XCHpAFvqw

Guests:

Dr. Breland Hockman, who is a board certified clinical chemist and the Director of Clinical Affairs at LetsGetChecked.com
Dr. Dina Greene, Clinical Professor at University of Washington, Department of Laboratory Medicine and Pathology and former Associate Lab Director at LetsGetChecked.com

Links:

Overcoming analytical and preanalytical challenges associated with extragenital home collected STI specimens
Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals.

This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro. Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript.

Follow JCM on Twitter/𝕏 via @JClinMicro

103 episodes

Editors in Conversation

At-Home Collection and Testing for STIs

Editors in Conversation

111 subscribers

published about a year ago

MP3•Episode home

So you want validated, at-home, self-collected swabs for STI testing… Here's what you need to know!

Watch this episode: https://youtu.be/40XCHpAFvqw

Guests:

Dr. Breland Hockman, who is a board certified clinical chemist and the Director of Clinical Affairs at LetsGetChecked.com
Dr. Dina Greene, Clinical Professor at University of Washington, Department of Laboratory Medicine and Pathology and former Associate Lab Director at LetsGetChecked.com

Links:

Overcoming analytical and preanalytical challenges associated with extragenital home collected STI specimens
Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals.

Follow JCM on Twitter/𝕏 via @JClinMicro

103 episodes

#Interviews #Jeff #Magazine #Microbiology #Society #Virology #News #Biology #Science #Natural Sciences #Microbe #American Society For Microbiology #ASME #FOX

All episodes

Editors in Conversation

1
Management of Pneumonia: Past, Present and Future 46:53

12 days ago46:53

46:53

In the last decade, there have been major changes in the approach of the treatment of pneumonia, in particular, with the availability of new diagnostic tools. Additionally, new drugs have been approved for the treatment of pneumonia. We discuss the approach to the management of pneumonia with a person who has spent most of his professional career working on this topic. Topics discussed: Definitions and nomenclature of pneumonia and evolution of these terms Changes in the diagnosis of pneumonia Ttherapeutic changes and future approaches for the treatment of pneumonia. Guest: Daniel M Musher, M.D. Links: ASM and IDSA launch the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) in 2026 This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal . Visit asm.org/ aa c to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/ joinasm to sign up.…

Editors in Conversation

1
Show Me the Light! Uv Light for Cyclospora 34:12

7 weeks ago34:12

34:12

Picture this, you wake up one morning with nausea, body aches, abdominal pain, and despite sleeping all night, you are exhausted. You then find yourself running to the restroom with watery and somewhat explosive diarrhea. You think to yourself – what could this be? Well, if the year was 2023, in the summer and you happen to live in Texas, chances were somewhat high that you had probably had cyclosporiasis. And today, we are going to talk about this particular parasite and focus in on what our options are for detecting it given that it is not routinely picked up on O&P exams. And while there are molecular panels out there that include Cyclospora as a target, as our speakers will share, there is an easier and cheaper approach we can consider to quickly ID this pathogen. Guests: Dr. Angela Ma. Public Health Ontario and Assistant Professor at the University of Toronto Dr. Marc Couturier. Drector of the clinical microbiology lab at NorDx lab at MaineHealth in Scarborough, Maine Links: Shedding new light on Cyclospora: how the use of ultraviolet fluorescence microscopy can improve diagnosis of cyclosporiasis Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. Attend ASM Microbe This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro . Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter/𝕏 via @JClinMicro…

Editors in Conversation

1
Best Papers in the Journal of Clinical Microbiology, 2024 1:01:02

14 weeks ago1:01:02

1:01:02

The past year in Clinical Microbiology, as seen through the lens of the Journal of Clinical Microbiology. Four JCM editors have each selected a paper they consider to be among the “best” we published in 2024. Of course there are no objective criteria for what makes a paper the “best.” So, by “best,” we mean “a paper that I find exciting.” View this episode: https://www.youtube.com/watch?v=fK9ZqZUrDiY Guests: Patricia Simner, Ph.D., D(ABMM) , Johns Hopkins University School of Medicine Romney Humphries, Ph.D., D(ABMM), M(ASCP ), Vanderbilt University Medical Center Links: Wood RC, Luabeya AK, Dragovich RB, Olson AM, Lochner KA, Weigel KM, Codsi R, Mulenga H, de Vos M, Kohli M, Penn-Nicholson A, Hatherill M, Cangelosi GA. 2024. Diagnostic accuracy of tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert MTB/RIF Ultra and Molbio Truenat MTB Ultima. J Clin Microbiol 62:e00019-24. Rodino KG, Luethy PM, Abbott AN, Bender JM, Eberly AR, Gitman M, Leber A, Dien Bard J, . 2024. Defining the value of medical microbiology consultation . J Clin Microbiol 62:e00359-24. Giske CG, Bressan M, Fiechter F, Hinic V, Mancini S, Nolte O, Egli A. 2024. GPT-4-based AI agents—the new expert system for detection of antimicrobial resistance mechanisms?. J Clin Microbiol 62:e00689-24. Bloomfield M, van der Werff K, Todd S, Bocacao M, Reed H, Balm M, Blackmore T. 2024. An exception-reporting approach for wound swab culture: effect on post-report antibiotic initiation . J Clin Microbiol 62:e00342-24. Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. Attend ASM Microbe This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro . Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter/𝕏 via @JClinMicro…

Editors in Conversation

1
Best Papers of AAC, 2024 54:12

17 weeks ago54:12

54:12

2024 was a very active year on research in antimicrobial resistance, highlighted by an impactful and high level political declaration to combat antimicrobial resistance by the United Nations. In this episode, trainees from NIH-funded training program (T32) on antimicrobial resistance will help me discuss the most relevant research on the field in the year 2024. Welcome to editors in conversation! Topics discussed: The best papers of 2024 in gram-positive, gram-negative, mycobacterial and parasite resistance Guests: Nathalie Chen: University of Pittsburgh, Pittsburgh, PA Alex Kang: Houston Methodist Research Institute, Houston, TX Nathan Rabbe: University of Pittsburgh, Pittsburgh, PA Taylor Blackburn: Emory University, Atlanta, GA Jacon McPherson: University of Houston, Houston, TX. Harrison Lee, MD: Associate Chief of Epidemiology and Microbial Genomics, Professor of Medicine and Epidemiology, Director, Center for Genomic Epidemiology, Director, T32 AMR, U of Pittsburgh William Shafer, PhD: Professor, Department of Microbiology and Immunology, Emory University School of Medicine, Co-Director, Emory Antibiotic Resistance Center. Director T32 AMR, Emory University This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal . Visit asm.org/ aa c to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/ joinasm to sign up.…

Editors in Conversation

1
Getting a Job in a Clinical Microbiology Lab 17:30

19 weeks ago17:30

17:30

Looking for a dynamic and rewarding career? Learn what it means to be a Clinical Microbiology Laboratory Director and the necessary steps to get there. It’s a diverse job encompassing infectious diseases diagnostic testing, patient care, teaching, and research. This episode is geared for those who are interested in pursuing (or already have) a Ph.D. or M.D. Guests: Alexandra Bryson, Ph.D. Andrea Prinzi, Ph.D Links: Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro . Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter/𝕏 via @JClinMicro…

Editors in Conversation

1
The Global Antibiotic Research & Development Partnership (GARDP) 41:04

23 weeks ago41:04

41:04

Lack of access to antibiotics including those with enhanced activity against multidrug-resistant organisms is a major barrier to combat antimicrobial resistance, particularly in the developing world. Furthermore, discovering and making available new antimicrobial agents against the most pressing antibiotic-resitant organisms is a challenge due to multiple barriers. The Global Antibiotic Research & Development Partnership (GARDP) accelerates the development and access of treatments for drug-resistant bacterial infections. Together with public, private and non-profit partners, GARDP works to preserve the power of antibiotics for generations to come. We discuss the important role that GARDP is playing in the worldwide fight against antimicrobial resistance. Topics discussed: GARDP function and role in the AMR field The strategies that GARDP is implementing to make new antibiotics available to all The future of antimicrobial research and development and the role of GARDP in this process. Guests: Jennifer Cohn MD MPH, Director, Global Access Global Antibiotic R&D Partnership (GARDP) Susana Ribeiro, MPH, Regional Head Latin America Global Antibiotic R&D Partnership (GARDP) This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal . Visit asm.org/aa c to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/ joinasm to sign up.…

Editors in Conversation

1
At-Home Collection and Testing for STIs 34:37

27 weeks ago34:37

34:37

So you want validated, at-home, self-collected swabs for STI testing… Here's what you need to know! Sexually transmitted infection rates continue to climb across the US and while testing for these diseases is widely available, for the most part it requires the patient to go to a local clinic to collect and submit their sample for testing. But, is that really necessary, especially from a test accuracy perspective? Today’s guests answer that exact question. And I’m sure that many, if not all of us would agree that the ability for patients to collect samples outside of a clinical setting has numerous benefits, including what the authors refer to as pseudo-anonymity, increased comfort and ultimately increased access to testing, which would be of particular value for patients that may avoid clinical settings due to various different socioeconomic barriers. Watch this episode: https://youtu.be/40XCHpAFvqw Guests: Dr. Breland Hockman, who is a board certified clinical chemist and the Director of Clinical Affairs at LetsGetChecked.com Dr. Dina Greene, Clinical Professor at University of Washington, Department of Laboratory Medicine and Pathology and former Associate Lab Director at LetsGetChecked.com Links: Overcoming analytical and preanalytical challenges associated with extragenital home collected STI specimens Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro . Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter/𝕏 via @JClinMicro…

Editors in Conversation

1
High Level Meeting on AMR at the United Nations: A Debrief 49:07

30 weeks ago49:07

49:07

The second High-Level Meeting on Antimicrobial Resistance (AMR) took place in New York on 26 September 2024 as the principal official, health-focused event during the UN General Assembly high-level week. The intergovernmental negotiations for the declaration were co-facilitated by Malta and Barbados. A political declaration for the meeting was produced highlighting the fact that AMR will cause even more global suffering, particularly in low- and middle-income countries. In this episode we will debrief and analyze the possible impact of these meetings and consequences for the future of AMR research and antimicrobial development. Topics discussed: The political implications of the UN declaration on AMR. Comment of the scientific and public health impact of the declaration Elaborate on future antimicrobial research and development Guests: John Rex, MD. Chief Medical Officer, F2G Ltd; Operating Partner, Advent Life Sciences Prabha Fernandes, PhD. Board Member of GARDP (Global Antibiotic Research and Development Partnership). Links: HLM on AMR at UNGA: The end of the beginning 29 April 2024: “ R&D Implications: Global Burden of Disease is 28% Infectious! ” 27 Sep 2024: “ Without action, AMR costs go from $66b to $159b/yr by 2050 ” This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal . Visit asm.org/aa c to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/ joinasm to sign up.…

Editors in Conversation

1
The Launch of ASM Case Reports Journal 30:27

32 weeks ago30:27

30:27

The American Society for Microbiology is launching a new journal, ASM Case Reports. The journal is already accepting submissions and will begin publishing in January of 2025. We discuss ASM Case Reports and what you can expect from this new journal. Watch this episode: https://youtu.be/zHdZL0PYTuE Some of the questions we will discuss include: What is the scope of ASM Case Reports? What makes a case report or case series interesting and important? Why should people publish in ASM Case Reports? Guests: Dr. Carey-Ann Burnham (twitter/𝕏) Learn more about ASM Case Reports Journal: journals.asm.org/journal/asmcr Links: Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro . Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter/𝕏 via @JClinMicro…

Editors in Conversation

1
Heteroresistance: Mechanisms, Diagnosis and Clinical Implications 42:54

36 weeks ago42:54

42:54

Heteroresistance is a phenomenon that has been well characterized for many years. However, we are only now starting to understand its mechanistic basis. Indeed, the manner how bacteria respond to antibiotics is complex and phenomena such as persistance, tolerance may be overlapping with heteroresistance. Furthermore, heteroresistance seems to be common in real clinical scenarios and understanding its basis is likely to open new avenues on how we deploy antibacterials in clinical practice., Today, we have experts in the field to discuss this important topic. Watch this episode at https://youtu.be/qcIcyn1bIHU. Topics discussed: The differences between heteroresistance, persistence and tolerance The mechanistic basis both in Gram-positive and Gram-negative bacteria The clinical implication and diagnosis of heteroresistance Guests: David Weiss, Ph.D. Professor of Medicine and Director Center for Antimicrobial Resistance, Emory University School Of Medicine, Atlanta. GA. William Miller, MD. Assistant Professor of Medicine, Houston Methodist, Houston, TX and Weill Cornell Medical College, New York, NY. Links: Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal . Visit asm.org/aa c to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/ joinasm to sign up. Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates. Subscribe to the podcast at https://asm.org/eic .…

Editors in Conversation

1
Microbiology in the Headlines: H5N1 in Dairy Cattle, The Plague, Measles, Neosporin and more! 28:37

40 weeks ago28:37

28:37

Join Dr. Ben Pinsky and Dr. Greg Berry as they dissect recent news stories, including the USDA's testing for H5N1 in ground beef and a surprising bubonic plague case in Oregon. They also tackle the resurgence of measles in the U.S., the local reappearance of malaria, and a curious study on Neosporin's potential to prevent viral infections. Overview: H5N1 Influenza Virus: Dr. Ben Pinsky provides an update on recent cases of H5N1 in humans and animals, including concerns about dairy cattle infections and the potential for human transmission. Bubonic Plague: Dr. Greg Berry discusses a recent case in Oregon, its transmission through cats, and the historical context of the plague. Measles: The resurgence of measles in the U.S. is addressed, with Dr. Pinsky noting an increase in cases compared to previous years and emphasizing the importance of vaccination. Malaria: The episode covers recent cases of locally acquired malaria in the U.S. and discusses the history of malaria in America. Neosporin and Viral Infections: The hosts examine a study suggesting Neosporin might prevent viral infections and discuss the implications and practicality of this claim. Guests: Dr. Ben Pinsky Dr. Greg Berry Links: Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro . Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter/𝕏 via @JClinMicro…

Editors in Conversation

1
The Global Preclinical Antibacterial Pipeline 38:20

43 weeks ago38:20

38:20

The pipeline of antibiotic discovery is a major necessity due to the continuous evolution of resistance to currently used antimicrobials. This pipeline faces important challenges due to the lack of investment on antimicrobial research in the private sector and an economic model that discourages investment. In the last few years, however, encouraging signs are occurring but major gaps still remain. The World Health Organization has regularly assessed the preclinical and clinical antibacterial development pipeline and the latest report is now available in the journal, lets discuss it! Watch this episode: https://youtu.be/IgqWmHDIx-0 Topics discussed: The process for review of the antibacterial pipeline. The progress and gaps in antibiotic discovery The opportunities to overcome the numerous hurdles in the early stages of the antibacterial research and development space Guest: Valeria Gigante Ph.D., Team Lead at the World Health Organization's (WHO) in the AMR Division, Geneva, Switzerland. Link: Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps. This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org . If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up. Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.…

Editors in Conversation

1
Turning the Output of the Microbiology Laboratory Into Gold 42:07

47 weeks ago42:07

42:07

The European alchemists of the 12th century sought to find the philosopher’s stone, a substance that would transmute base metals, such as lead, into precious metals, such as silver and gold. Today, we discuss whether data analysis, including machine learning, can transmute base laboratory data into precious clinical tools. We will use antimicrobial susceptibility testing as a case-study for new applications of data analysis. Some of the questions we will address include: How can relatively simple data analyses be used to build upon current methods of verification of antimicrobial susceptibility testing? How do commercial systems analyze individual susceptibility results and can we improve on this analysis using new methods? Finally, what is the long-term potential for leveraging laboratory data and other clinical data to improve and support clinical decision making? And what needs to happen to realize this goal? Guests: Dr. Sanjat Kanjilal (twitter/𝕏) Related article: The modern alchemy of clinical pathology: turning the output of microbiology laboratory operations into gold Links: Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. Watch this episode: youtu.be/rWuQ0nSWL1Y This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro . Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript.…

Editors in Conversation

1
Training in Antimicrobial Resistance: Gaps and Opportunities 40:31

51 weeks ago40:31

40:31

Antimicrobial resistance is a priority public health problem with complex roots and connotations. However, due to a lack of focus on this topic, research training programs, specifically those focused on AMR are limited. Additionally, scientific meetings that particularly highlight the science of antimicrobial resistance are scarce. We recently published a commentary that evaluates the state-of-the-art of the training programs in AMR in the US. We discuss this topic with the leading author and discussed the issue with leaders in the field. Topics discussed: The challenges that training in AMR poses and how to approach them. The current status of training programs in the USA Specific strategies that could improve the access and dissemination of AMR research Guest: William M Shafer, PhD, Professor, Department of Microbiology and Immunology; Director Antimicrobial Resistance and Therapeutic Discovery Training Program. Lee H. Harrison, M.D. Professor of Medicine and Epidemiology, Associate chief of epidemiology and education Division of Infectious Diseases, University of Pittsburgh School of Medicine. Director University of Pittsburgh Antimicrobial Resistance T32 Program Links: Ensuring a sustained workforce to combat antibiotic resistance in the 21st century: the critical need for training the next-gen of scientists at the pre-doctoral level This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org . If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up. Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.…

Editors in Conversation

1
10 Years of Rhodococcus: Clinical Trends and Susceptibility Profiles 37:38

1 year ago37:38